Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
Smolders J, Hupperts R, Barkhof F, Grimaldi LME, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, et al.
J Neurol Sci. 2011 Dec 15; 311(1-2):44-9. PMID: 21620416.Abstract